Overview
The purpose of this study is to evaluate topotecan and melphalan for retinoblastoma patients.
Description
To evaluate the effectiveness and complications of topotecan and melphalan for intraocular injection in retinoblastoma patients.
Eligibility
Inclusion Criteria:
- diagnosed as retinoblastoma
- receiving eyeball-sparing treatment
Exclusion Criteria:
- disease progression during follow-up